AI News NQ Analysis

Securities Report - 80th Period (2025/04/01 - 2026/03/31)

Key facts

  • Securities Report - 80th Period (2025/04/01 - 2026/03/31)
  • Suzken Co., Ltd. has filed its securities report for the 80th period (April 1, 2025 - March 31, 2026). The report discloses financial condition, business performance, future outlook, and risk factors, serving as crucial information for investors.
  • Source: EDINET
  • Date: Mon Jun 22 2026 20:33:00 GMT+0900 (Japan Standard Time)

Direct answer

Suzken Co., Ltd. has filed its securities report for the 80th period (April 1, 2025 - March 31, 2026). The report discloses financial condition, business performance, future outlook, and risk factors, serving as crucial information for investors.

Citation
Securities Report - 80th Period (2025/04/01 - 2026/03/31) (Mon Jun 22 2026 20:33:00 GMT+0900 (Japan Standard Time)), EDINET
Source
EDINET
Date
Mon Jun 22 2026 20:33:00 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Suzken Co., Ltd. has filed its securities report for the 80th period (April 1, 2025 - March 31, 2026). The report discloses financial condition, business performance, future outlook, and risk factors, serving as crucial information for investors.

AI Analysis

Frequently Asked Questions

Q: What is a securities report?
A: A mandatory document filed by listed companies to disclose financial and operational performance, used by investors for evaluation.
Q: Where is Suzken's headquarters located?
A: In Dotonbori, Chuo Ward, Osaka City. It is a pharmaceutical company with nationwide operations based in the Kansai region.
Q: What are Suzken's main products?
A: Prescription and OTC pharmaceuticals, with strengths in gastrointestinal and cardiovascular products.